Cardiovascular Mortality Reduction With Empagliflozin in Patients With Type 2 Diabetes and Cardiovascular Disease

Cardiovascular Mortality Reduction With Empagliflozin in Patients With Type 2 Diabetes and Cardiovascular Disease

Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Journal of the American College of Cardiology - Volume 71, Issue 3, 23 January 2018, Pages 364-367

David MD, Silvio E. MD, John M. ScD, Christoph MD, Philippe MD, Michaela Dipl Biomath, Odd Erik MD, PhD, Hans J. MD, Uli C. MD, Jyothis T. MBBS, PhD, Bernard MD, EMPA-REG OUTCOME Investigators EMPA-REG OUTCOME Investigators,